USD 29.84
(-4.56%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 59.58 Million USD | 13.3% |
2022 | 50.39 Million USD | 12.32% |
2021 | 44.86 Million USD | -2.48% |
2020 | 46 Million USD | 8.03% |
2019 | 42.58 Million USD | 7.22% |
2018 | 39.72 Million USD | 10.09% |
2017 | 33.45 Million USD | 29.92% |
2016 | 28.35 Million USD | -9.1% |
2015 | 30.55 Million USD | 11.89% |
2014 | 27.3 Million USD | 21.26% |
2013 | 22.51 Million USD | 11.92% |
2012 | 20.12 Million USD | 19.7% |
2011 | 16.8 Million USD | 40.54% |
2010 | 11.95 Million USD | 16.38% |
2009 | 10.28 Million USD | 38.05% |
2008 | 7.44 Million USD | 15.97% |
2007 | 6.41 Million USD | 33.71% |
2006 | 4.79 Million USD | 12.12% |
2005 | 4.27 Million USD | 423.13% |
2004 | 815.89 Thousand USD | 209.87% |
2003 | -751.23 Thousand USD | 90.61% |
2002 | -7.96 Million USD | 21.9% |
2001 | -11.44 Million USD | 36.07% |
2000 | -15.89 Million USD | -287.62% |
1999 | -4.1 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 16.57 Million USD | 12.11% |
2024 Q2 | 14.78 Million USD | -7.77% |
2024 Q1 | 16.02 Million USD | 8.42% |
2023 Q3 | 15.26 Million USD | 7.28% |
2023 Q1 | 12.81 Million USD | 1.0% |
2023 Q2 | 14.23 Million USD | 11.02% |
2023 FY | - USD | 13.3% |
2023 Q4 | 14.78 Million USD | -3.17% |
2022 Q1 | 13.35 Million USD | 49.91% |
2022 FY | - USD | 12.32% |
2022 Q4 | 12.69 Million USD | 5.98% |
2022 Q2 | 12.37 Million USD | -7.37% |
2022 Q3 | 11.97 Million USD | -3.22% |
2021 Q3 | 10.92 Million USD | -13.15% |
2021 Q2 | 12.58 Million USD | 1.02% |
2021 Q1 | 12.45 Million USD | 33.6% |
2021 FY | - USD | -2.48% |
2021 Q4 | 8.91 Million USD | -18.45% |
2020 FY | - USD | 8.03% |
2020 Q3 | 10.54 Million USD | -7.98% |
2020 Q4 | 9.32 Million USD | -11.57% |
2020 Q1 | 14.69 Million USD | 38.91% |
2020 Q2 | 11.45 Million USD | -22.04% |
2019 Q2 | 9.21 Million USD | -22.66% |
2019 Q4 | 10.57 Million USD | -2.94% |
2019 FY | - USD | 7.22% |
2019 Q1 | 11.9 Million USD | 32.74% |
2019 Q3 | 10.89 Million USD | 18.32% |
2018 Q2 | 10.28 Million USD | 4.9% |
2018 Q4 | 8.97 Million USD | -15.9% |
2018 FY | - USD | 10.09% |
2018 Q1 | 9.8 Million USD | 23.71% |
2018 Q3 | 10.66 Million USD | 3.73% |
2017 Q2 | 9.38 Million USD | 14.18% |
2017 FY | - USD | 29.92% |
2017 Q4 | 7.92 Million USD | -24.91% |
2017 Q3 | 10.55 Million USD | 12.42% |
2017 Q1 | 8.22 Million USD | 43.96% |
2016 Q1 | 7.62 Million USD | 13.38% |
2016 FY | - USD | -9.1% |
2016 Q4 | 5.71 Million USD | -18.9% |
2016 Q3 | 7.04 Million USD | -4.81% |
2016 Q2 | 7.39 Million USD | -3.02% |
2015 FY | - USD | 11.89% |
2015 Q4 | 6.72 Million USD | -24.96% |
2015 Q3 | 8.96 Million USD | 31.44% |
2015 Q2 | 6.82 Million USD | -15.21% |
2015 Q1 | 8.04 Million USD | 11.41% |
2014 Q1 | 5.69 Million USD | 2.7% |
2014 FY | - USD | 21.26% |
2014 Q2 | 6.83 Million USD | 19.88% |
2014 Q3 | 7.55 Million USD | 10.6% |
2014 Q4 | 7.21 Million USD | -4.46% |
2013 Q3 | 5.91 Million USD | -1.42% |
2013 Q2 | 6 Million USD | 18.89% |
2013 Q1 | 5.04 Million USD | -3.42% |
2013 Q4 | 5.54 Million USD | -6.24% |
2013 FY | - USD | 11.92% |
2012 Q3 | 5.45 Million USD | -3.47% |
2012 FY | - USD | 19.7% |
2012 Q1 | 3.9 Million USD | -13.96% |
2012 Q4 | 5.22 Million USD | -4.18% |
2012 Q2 | 5.65 Million USD | 44.7% |
2011 Q4 | 4.54 Million USD | 8.87% |
2011 Q2 | 4.47 Million USD | 23.16% |
2011 Q1 | 3.62 Million USD | 33.02% |
2011 Q3 | 4.17 Million USD | -6.71% |
2011 FY | - USD | 40.54% |
2010 FY | - USD | 16.38% |
2010 Q2 | 3.58 Million USD | 27.95% |
2010 Q3 | 2.83 Million USD | -20.96% |
2010 Q4 | 2.72 Million USD | -3.82% |
2010 Q1 | 2.8 Million USD | 9.21% |
2009 Q1 | 2.21 Million USD | -9.94% |
2009 Q3 | 2.38 Million USD | -23.43% |
2009 Q2 | 3.11 Million USD | 41.08% |
2009 Q4 | 2.56 Million USD | 7.54% |
2009 FY | - USD | 38.05% |
2008 Q2 | 1.93 Million USD | 49.86% |
2008 FY | - USD | 15.97% |
2008 Q4 | 2.45 Million USD | 39.07% |
2008 Q1 | 1.28 Million USD | -35.51% |
2008 Q3 | 1.76 Million USD | -8.68% |
2007 Q2 | 1.6 Million USD | 109.97% |
2007 Q3 | 2.04 Million USD | 27.45% |
2007 Q4 | 2 Million USD | -2.28% |
2007 Q1 | 764.96 Thousand USD | -56.45% |
2007 FY | - USD | 33.71% |
2006 Q1 | 1.19 Million USD | -32.31% |
2006 Q4 | 1.75 Million USD | 66.67% |
2006 Q2 | 795.6 Thousand USD | -33.27% |
2006 Q3 | 1.05 Million USD | 32.46% |
2006 FY | - USD | 12.12% |
2005 Q3 | 1.13 Million USD | 58.64% |
2005 Q4 | 1.76 Million USD | 55.3% |
2005 Q2 | 715.01 Thousand USD | 7.7% |
2005 Q1 | 663.92 Thousand USD | -11.06% |
2005 FY | - USD | 423.13% |
2004 Q3 | 294.95 Thousand USD | 525.11% |
2004 FY | - USD | 209.87% |
2004 Q2 | -69.38 Thousand USD | -463.17% |
2004 Q1 | 19.1 Thousand USD | 19.66% |
2004 Q4 | 746.45 Thousand USD | 153.08% |
2003 Q3 | 78.59 Thousand USD | 130.23% |
2003 FY | - USD | 90.61% |
2003 Q4 | 15.96 Thousand USD | -79.69% |
2003 Q1 | -585.82 Thousand USD | 65.52% |
2003 Q2 | -259.96 Thousand USD | 55.62% |
2002 Q1 | -2.51 Million USD | 6.28% |
2002 FY | - USD | 21.9% |
2002 Q4 | -1.69 Million USD | -15.49% |
2002 Q3 | -1.47 Million USD | 35.4% |
2002 Q2 | -2.27 Million USD | 9.59% |
2001 Q2 | -2.69 Million USD | 6.31% |
2001 Q1 | -2.55 Million USD | 42.36% |
2001 FY | - USD | 36.07% |
2001 Q4 | -3.46 Million USD | 1.36% |
2001 Q3 | -2.72 Million USD | -18.68% |
2000 Q1 | -2.63 Million USD | 0.0% |
2000 Q2 | -4.47 Million USD | -70.04% |
2000 FY | - USD | -287.62% |
2000 Q3 | -4.52 Million USD | -1.03% |
2000 Q4 | -4.25 Million USD | 6.06% |
1999 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CareCloud, Inc. | -31.29 Million USD | 290.435% |
Augmedix, Inc. | -17.68 Million USD | 437.011% |
BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 82.952% |
CareCloud, Inc. | -31.29 Million USD | 290.435% |
HealthEquity, Inc. | 282.41 Million USD | 78.901% |
iCoreConnect Inc. | -11.87 Million USD | 601.6% |
Inovalon Holdings, Inc. | 186.56 Million USD | 68.061% |
Nutex Health, Inc. | -14.58 Million USD | 508.652% |
Omnicell, Inc. | 60.69 Million USD | 1.817% |
OneMedNet Corporation | -11.97 Million USD | 597.771% |
Progyny, Inc. | 64.46 Million USD | 7.567% |
Renalytix Plc | -28.52 Million USD | 308.923% |
Schrödinger, Inc. | -171.89 Million USD | 134.665% |
Simulations Plus, Inc. | 6.13 Million USD | -871.897% |
SOPHiA GENETICS SA | -70.7 Million USD | 184.281% |
Streamline Health Solutions, Inc. | -12.81 Million USD | 564.942% |
Ontrak, Inc. | -14.41 Million USD | 513.339% |
GE HealthCare Technologies Inc. | 3.56 Billion USD | 98.326% |
Sharecare, Inc. | -67.25 Million USD | 188.6% |
Aclarion, Inc. | -4.14 Million USD | 1539.156% |
CareMax, Inc. | -590.46 Million USD | 110.092% |
Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 1229.6% |
Forian Inc. | 2.75 Million USD | -2066.571% |
Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 1229.6% |
HeartBeam, Inc. | 675 Thousand USD | -8727.704% |
GeneDx Holdings Corp. | -136.46 Million USD | 143.666% |
SCWorx Corp. | -3.97 Million USD | 1599.159% |
Minerva Surgical, Inc. | -20.07 Million USD | 396.851% |
Definitive Healthcare Corp. | -241.22 Million USD | 124.702% |
10x Genomics, Inc. | -205.11 Million USD | 129.051% |
Zhongchao Inc. | -4.9 Million USD | 1315.478% |
Accolade, Inc. | -71.19 Million USD | 183.698% |
MSP Recovery, Inc. | -69.22 Million USD | 186.082% |
R1 RCM Inc. | 426.2 Million USD | 86.019% |
Spok Holdings, Inc. | 26.29 Million USD | -126.592% |
Privia Health Group, Inc. | 27.18 Million USD | -119.215% |
EUDA Health Holdings Limited | -8.3 Million USD | 817.885% |
TruBridge, Inc. | -15.39 Million USD | 487.155% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 82.952% |
Sharecare, Inc. | -67.25 Million USD | 188.6% |
Health Catalyst, Inc. | -66.46 Million USD | 189.656% |
GoodRx Holdings, Inc. | 108.82 Million USD | 45.245% |
Premier, Inc. | 286.08 Million USD | 79.172% |
Certara, Inc. | 23.84 Million USD | -149.904% |
GeneDx Holdings Corp. | -136.46 Million USD | 143.666% |
Ontrak, Inc. | -14.41 Million USD | 513.339% |
SHL Telemedicine Ltd. | 3.28 Million USD | -1714.733% |
CareCloud, Inc. | -31.29 Million USD | 290.435% |
EUDA Health Holdings Limited | -8.3 Million USD | 817.885% |
HeartBeam, Inc. | 675 Thousand USD | -8727.704% |
Mangoceuticals, Inc. | -9.18 Million USD | 748.564% |
CareMax, Inc. | -590.46 Million USD | 110.092% |
Healthcare Triangle, Inc. | -4.1 Million USD | 1551.925% |
National Research Corporation | 45.98 Million USD | -29.579% |
Aclarion, Inc. | -4.14 Million USD | 1539.156% |
OptimizeRx Corporation | -21.3 Million USD | 379.641% |